CRSP - CRISPR Therapeutics AG
60
1.940 3.233%
Share volume: 1,170,589
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$58.06
1.94
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-05-2024 | 11-05-2024 | 02-11-2025 | 05-06-2025 | 08-04-2025 | 11-10-2025 | 02-12-2026 | |
| Total revenue | 504.000 K | 517.000 K | 602.000 K | 35.691 M | 865.000 K | 892.000 K | 889.000 K | 864.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 504.000 K | 517.000 K | 602.000 K | 35.691 M | 865.000 K | 892.000 K | 889.000 K | 864.000 K | |
| 2.58% | 16.44% | 5,828.74% | -97.58% | 3.12% | -0.34% | -2.81% | |||
| Operating expenses | 94.125 M | 99.646 M | 99.579 M | 100.280 M | 91.780 M | 185.063 M | 75.833 M | 101.925 M | |
| Selling general and admin | 17.953 M | 19.481 M | 17.419 M | 18.124 M | 19.296 M | 18.916 M | 16.931 M | 18.399 M | |
| Research and development | 76.172 M | 80.165 M | 82.160 M | 82.156 M | 72.484 M | 166.147 M | 58.902 M | 83.526 M | |
| Total expenses | 141.091 M | 151.777 M | 110.732 M | 100.280 M | 149.289 M | 230.216 M | 132.948 M | 155.628 M | |
| 7.57% | -27.04% | -9.44% | 48.87% | 54.21% | -42.25% | 17.06% | |||
| Operating income | -140.587 M | -151.260 M | -110.130 M | -64.589 M | -148.424 M | -229.324 M | -132.059 M | -154.764 M | |
| Ebit | -115.867 M | -125.121 M | -85.066 M | -36.611 M | -134.887 M | -207.257 M | -105.822 M | -129.999 M | |
| Pretax income | -115.867 M | -125.121 M | -85.066 M | -36.611 M | -134.887 M | -207.257 M | -105.822 M | -129.999 M | |
| 7.99% | -32.01% | -56.96% | 268.43% | 53.65% | -48.94% | 22.85% | |||
| Income tax | 724.000 K | 1.287 M | 876.000 K | 700.000 K | 1.109 M | 1.292 M | 619.000 K | 614.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -116.591 M | -126.408 M | -85.942 M | -37.311 M | -135.996 M | -208.549 M | -106.441 M | -130.613 M | |
| -8.42% | 32.01% | 56.59% | -264.49% | -53.35% | 48.96% | -22.71% |